WallStreetZenWallStreetZen

NASDAQ: AMLX
Amylyx Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for AMLX

Based on 3 analysts offering 12 month price targets for Amylyx Pharmaceuticals Inc.
Min Forecast
$49.00+165.15%
Avg Forecast
$49.67+168.76%
Max Forecast
$50.00+170.56%

Should I buy or sell AMLX stock?

Based on 3 analysts offering ratings for Amylyx Pharmaceuticals Inc.
Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AMLX stock forecasts and price targets.

AMLX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$50.00+170.56%2023-08-11
Goldman Sachs
Top 12%
89
Strong BuyUpgrades$49.00+165.15%2023-07-24Find out why
Mizuho
Bottom 4%
4
Strong BuyMaintains$50.00+170.56%2023-05-15

1 of 1

Forecast return on equity

Is AMLX forecast to generate an efficient return?
Company
N/A
Industry
0.91%
Market
28.82%

Forecast return on assets

Is AMLX forecast to generate an efficient return on assets?
Company
N/A
Industry
0.07%

AMLX revenue growth forecast

How is AMLX forecast to perform vs Biotechnology companies and vs the US market?
Company
60.34%
Industry
35.95%
Market
8.15%
AMLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMLX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMLX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AMLX$18.48$49.67+168.76%Strong Buy
VIR$9.35$35.83+283.24%Buy
XNCR$20.16$38.33+90.14%Strong Buy
ARVN$22.72$62.30+174.21%Strong Buy
IOVA$4.87$23.89+390.53%Strong Buy
View Top Biotech Stocks

Amylyx Pharmaceuticals Stock Forecast FAQ

Is Amylyx Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: AMLX) stock is to Strong Buy AMLX stock.

Out of 3 analysts, 2 (66.67%) are recommending AMLX as a Strong Buy, 1 (33.33%) are recommending AMLX as a Buy, 0 (0%) are recommending AMLX as a Hold, 0 (0%) are recommending AMLX as a Sell, and 0 (0%) are recommending AMLX as a Strong Sell.

If you're new to stock investing, here's how to buy Amylyx Pharmaceuticals stock.

What is AMLX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: AMLX) forecast ROE is N/A, which is considered weak.

What is AMLX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AMLX price target, the average AMLX price target is $49.67, with the highest AMLX stock price forecast at $50.00 and the lowest AMLX stock price forecast at $49.00.

On average, Wall Street analysts predict that Amylyx Pharmaceuticals's share price could reach $49.67 by Aug 11, 2024. The average Amylyx Pharmaceuticals stock price prediction forecasts a potential upside of 168.76% from the current AMLX share price of $18.48.

What is AMLX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: AMLX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.